Report from the 7th International Lipodystrophy Meeting.
Judith
J
Currier
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D050171:Dyslipidemias / Q000188:drug therapy; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced / Q000150:complications / Q000628:therapy; D009525:Niacin / Q000627:therapeutic use
D019380:Anti-HIV Agents; D009525:Niacin